A beta-blocker and aspirin combination may help attenuate the heightened CVD risk observed in people who have recently lost a loved one, according to research published in the American Heart Journal in February.

Physicians who treat individuals with AFib may mistake gastrointestinal bleeding as a side effect of their patients’ blood thinners when it may, in fact, be an early warning sign for bowel cancer, according to a new study.

Over half of heart patients on a triple-drug regimen of ACE inhibitors, statins and either calcium channel blockers or aspirin are nonadherent to their medications, researchers reported in the American Journal of Cardiology Feb. 6.

A recent analysis of FitBit data suggests there is no one “normal” resting heart rate for humans, with users’ average HR coming in at between 40 and 109 beats per minute, Discover Magazine reported.

Research out of Ireland suggests end-of-life care needs will nearly double over the next three decades, corresponding to an increase of 84% by 2046.

The U.S. FDA on Feb. 6 granted Breakthrough Device Designation to medical device developer Aria CV, Inc., for its Aria CV Pulmonary Hypertension System.

People who begin taking antihypertensive drugs or lipid-lowerers like statins are more likely than non-initiators to become obese and physically inactive, a JAHA study has found—but they’re also more likely to quit smoking and keep their alcohol intake in check.

Despite other quality of life improvements, heart patients supported by left ventricular assist devices face “severely impaired” exercise capacity, according to a study published online in JACC: Heart Failure.